Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor

Hypercalcemia is a clinical problem that is commonly seen in both the inpatient and outpatient settings. Overall, most common causes of hypercalcemia include hyperparathyroidism and malignancy. Our case report is the presentation of hypercalcemia in a patient eventually diagnosed with a vasoactive i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ataallah, Basma, Buttar, Barjinder S, Kulina, Georgia, Kaell, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058397/
https://www.ncbi.nlm.nih.gov/pubmed/32190445
http://dx.doi.org/10.7759/cureus.6882
_version_ 1783503855451897856
author Ataallah, Basma
Buttar, Barjinder S
Kulina, Georgia
Kaell, Alan
author_facet Ataallah, Basma
Buttar, Barjinder S
Kulina, Georgia
Kaell, Alan
author_sort Ataallah, Basma
collection PubMed
description Hypercalcemia is a clinical problem that is commonly seen in both the inpatient and outpatient settings. Overall, most common causes of hypercalcemia include hyperparathyroidism and malignancy. Our case report is the presentation of hypercalcemia in a patient eventually diagnosed with a vasoactive intestinal peptide tumor, a type of neuroendocrine tumor, without associated hyperparathyroidism.
format Online
Article
Text
id pubmed-7058397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70583972020-03-18 Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor Ataallah, Basma Buttar, Barjinder S Kulina, Georgia Kaell, Alan Cureus Endocrinology/Diabetes/Metabolism Hypercalcemia is a clinical problem that is commonly seen in both the inpatient and outpatient settings. Overall, most common causes of hypercalcemia include hyperparathyroidism and malignancy. Our case report is the presentation of hypercalcemia in a patient eventually diagnosed with a vasoactive intestinal peptide tumor, a type of neuroendocrine tumor, without associated hyperparathyroidism. Cureus 2020-02-04 /pmc/articles/PMC7058397/ /pubmed/32190445 http://dx.doi.org/10.7759/cureus.6882 Text en Copyright © 2020, Ataallah et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Ataallah, Basma
Buttar, Barjinder S
Kulina, Georgia
Kaell, Alan
Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title_full Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title_fullStr Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title_full_unstemmed Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title_short Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
title_sort hypercalcemia in a patient diagnosed with a vasoactive intestinal peptide tumor
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058397/
https://www.ncbi.nlm.nih.gov/pubmed/32190445
http://dx.doi.org/10.7759/cureus.6882
work_keys_str_mv AT ataallahbasma hypercalcemiainapatientdiagnosedwithavasoactiveintestinalpeptidetumor
AT buttarbarjinders hypercalcemiainapatientdiagnosedwithavasoactiveintestinalpeptidetumor
AT kulinageorgia hypercalcemiainapatientdiagnosedwithavasoactiveintestinalpeptidetumor
AT kaellalan hypercalcemiainapatientdiagnosedwithavasoactiveintestinalpeptidetumor

Ejemplares similares